Bill Texts: NJ S4601 | 2026-2027 | Regular Session

Bill Title: Requires pharmacist or pharmacist's designee to notify consumer of substituted drug or biological product.

Sponsorship: Partisan Bill (Democrat 3)

Status: (Engrossed) 2026-10-29 - Received in the Assembly, Referred to Assembly Health Committee [S4601 Detail]

Bill Drafts

RevisionDateFormatSourceView
Amended2026-10-06HTML/TextLinkView
Introduced2026-09-29HTML/TextLinkView

Amendments

AmendmentDateDispositionFormatSourceView
No bill amendments currently on file for New Jersey S4601

Supplemental Documents

TitleDescriptionDateFormatSourceView
AnalysisStatement SHH 10/5/26Not AvailPDFLinkView

feedback